Brief: Tandem Diabetes Care Q3 Adjusted Operating Income USD -26.5 Million Vs. IBES Estimate USD -29.4 Million
06/11/2024 21:05
Nov 06 (Reuters) - Tandem Diabetes Care Q3 operating income USD -26.1 million. * Q3 net income USD -23.3 million * Q3 gross margin 51% * Q3 adjusted net income USD -23.6 million vs. IBES estimate USD -28 million * outlook FY adjusted sales USD 903-910 million
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary